Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China · Delayed Price · Currency is CNY 28.74
+0.89 (3.20%)
Jul 10, 2026, 3:00 PM CST
SHA:603392 Market Cap
SHA:603392 has a market cap or net worth of 36.34 billion as of July 10, 2026. Its market cap has decreased by -55.87% in one year.
Market Cap
36.34B
Enterprise Value
32.55B
Revenue
1.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
28.74
Market Cap Chart
Since April 29, 2020, SHA:603392's market cap has increased from 5.46B to 36.34B, an increase of 565.13%. That is a compound annual growth rate of 35.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 36.34B | -36.05% |
| Dec 31, 2025 | 56.82B | -36.26% |
| Dec 31, 2024 | 89.14B | -6.44% |
| Dec 29, 2023 | 95.28B | -17.00% |
| Dec 30, 2022 | 114.80B | -14.62% |
| Dec 31, 2021 | 134.46B | 53.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Allist Pharmaceuticals | 54.74B |
| Asymchem Laboratories (Tianjin) | 52.27B |
| Pharmaron Beijing | 50.97B |
| Sunshine Guojian Pharmaceutical (Shanghai) | 44.90B |
| Suzhou Zelgen Biopharmaceuticals | 36.23B |
| Shanghai RAAS Blood Products | 29.77B |
| Chongqing Zhifei Biological Products | 27.22B |
| Beijing Tiantan Biological Products | 23.45B |